Literature DB >> 17608628

Fucoganglioside alpha-fucosyl(alpha-galactosyl)-GM1: a novel member of lipid membrane microdomain components involved in PC12 cell neuritogenesis.

Yasuhiro Yamazaki1, Yasuhiro Horibata, Yasuko Nagatsuka, Yoshio Hirabayashi, Tsutomu Hashikawa.   

Abstract

In order to search for novel components of lipid membrane microdomains involved in neural signalling pathways, mAbs (monoclonal antibodies) were raised against the detergent-insoluble membrane fraction of PC12 (pheochromocytoma) cells. Among the 22 hybrid clones, mAb PR#1 specifically detected a fucoganglioside Fuc(Gal)-GM1 [a-fucosyl(a-galactosyl)-GM1], a ganglioside homologous with GM1a (II3NeuAc,GgOse4Cer), as a novel member of microdomain components with biological functions. In the presence of mAb PR#1 in the culture medium, the outgrowth of neurites was induced in PC12 cells in a dose-dependent manner, with no effects on cell proliferation, suggesting that Fuc(Gal)-GM1 is preferentially involved in PC12 cell neuritogenesis. Effects through Fuc(Gal)-GM1 were different from those through GM1a during differentiation, e.g. under PR#1 treatment on Fuc(Gal)-GM1, round cell bodies with thinner cell processes were induced, whereas treatment with CTB (cholera toxin B subunit), a specific probe for GM1a, produced flattened cell bodies with thicker pro-cesses. Molecular analysis demonstrated that the PR#1-Fuc(Gal)-GM1 pathway was associated with Fyn and Yes of the Src family of kinases, although Src itself was not involved. No association was found with TrkA (tropomyosin receptor kinase A) and ERKs (extracellular-signal-regulated kinases), which are responsible for GM1a-induced differentiation. From these findings, it is suggested that a fucoganglioside Fuc(Gal)-GM1 provides a functional platform distinct from that of GM1a for signal transduction in PC12 cell differentiation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17608628      PMCID: PMC2267403          DOI: 10.1042/BJ20070090

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  41 in total

1.  Developmental changes of C-series polysialogangliosides in chick brains revealed by mouse monoclonal antibodies M6704 and M7103 with different epitope specificities.

Authors:  Y Hirabayashi; M Hirota; M Matsumoto; H Tanaka; K Obata; S Ando
Journal:  J Biochem       Date:  1988-12       Impact factor: 3.387

Review 2.  Bifunctional role of glycosphingolipids. Modulators for transmembrane signaling and mediators for cellular interactions.

Authors:  S Hakomori
Journal:  J Biol Chem       Date:  1990-11-05       Impact factor: 5.157

3.  Sensitive enzyme-immunostaining and densitometric determination on thin-layer chromatography of N-glycolylneuraminic acid-containing glycosphingolipids, Hanganutziu-Deicher antigens.

Authors:  H Higashi; Y Fukui; S Ueda; S Kato; Y Hirabayashi; M Matsumoto; M Naiki
Journal:  J Biochem       Date:  1984-05       Impact factor: 3.387

4.  Characterization of tumor-associated fucogangliosides from PC 12 pheochromocytoma cells.

Authors:  T Ariga; K Kobayashi; Y Kuroda; R K Yu; M Suzuki; H Kitagawa; F Inagaki; T Miyatake
Journal:  J Biol Chem       Date:  1987-10-15       Impact factor: 5.157

5.  Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface.

Authors:  D A Brown; J K Rose
Journal:  Cell       Date:  1992-02-07       Impact factor: 41.582

6.  The effect of the B subunit of cholera toxin on the action of nerve growth factor on PC12 cells.

Authors:  T Mutoh; A Tokuda; G Guroff; N Fujiki
Journal:  J Neurochem       Date:  1993-04       Impact factor: 5.372

7.  Complex glycosphingolipids of the pheochromocytoma cell line PC12: enhanced fucosylglycolipid synthesis following nerve growth factor treatment.

Authors:  G A Schwarting; A Gajewski; L Barbero; A S Tischler; D Costopoulos
Journal:  Neuroscience       Date:  1986-10       Impact factor: 3.590

8.  Fuc-GM1 ganglioside mimics the receptor function of GM1 for cholera toxin.

Authors:  M Masserini; E Freire; P Palestini; E Calappi; G Tettamanti
Journal:  Biochemistry       Date:  1992-03-03       Impact factor: 3.162

9.  Effect of nerve growth factor and forskolin on glycosyltransferase activities and expression of a globo-series glycosphingolipid in PC12D pheochromocytoma cells.

Authors:  T Kanda; T Ariga; M Yamawaki; S Pal; R Katoh-Semba; R K Yu
Journal:  J Neurochem       Date:  1995-02       Impact factor: 5.372

10.  Transcriptional and post-transcriptional effects of nerve growth factor on expression of the three neurofilament subunits in PC-12 cells.

Authors:  M H Lindenbaum; S Carbonetto; F Grosveld; D Flavell; W E Mushynski
Journal:  J Biol Chem       Date:  1988-04-25       Impact factor: 5.157

View more
  5 in total

Review 1.  Role of ganglioside metabolism in the pathogenesis of Alzheimer's disease--a review.

Authors:  Toshio Ariga; Michael P McDonald; Robert K Yu
Journal:  J Lipid Res       Date:  2008-03-11       Impact factor: 5.922

2.  Clostridium perfringens alpha-toxin recognizes the GM1a-TrkA complex.

Authors:  Masataka Oda; Michiko Kabura; Teruhisa Takagishi; Ayaka Suzue; Kaori Tominaga; Shiori Urano; Masahiro Nagahama; Keiko Kobayashi; Keiko Furukawa; Koichi Furukawa; Jun Sakurai
Journal:  J Biol Chem       Date:  2012-07-30       Impact factor: 5.157

3.  The pathological roles of ganglioside metabolism in Alzheimer's disease: effects of gangliosides on neurogenesis.

Authors:  Toshio Ariga; Chandramohan Wakade; Robert K Yu
Journal:  Int J Alzheimers Dis       Date:  2011-01-09

Review 4.  Role of Ceramide from Glycosphingolipids and Its Metabolites in Immunological and Inflammatory Responses in Humans.

Authors:  Kazuhisa Iwabuchi; Hitoshi Nakayama; Ami Oizumi; Yasushi Suga; Hideoki Ogawa; Kenji Takamori
Journal:  Mediators Inflamm       Date:  2015-11-01       Impact factor: 4.711

Review 5.  Membrane-Binding Mechanism of Clostridium perfringens Alpha-Toxin.

Authors:  Masataka Oda; Yutaka Terao; Jun Sakurai; Masahiro Nagahama
Journal:  Toxins (Basel)       Date:  2015-12-03       Impact factor: 4.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.